1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Hormonal Therapy 1.2.3 Adding An Anti-Androgen 1.2.4 Stopping An Anti-Androgen 1.2.5 Estrogens 1.2.6 Chemotherapy 1.2.7 Radiation Therapy 1.2.8 Others 1.3 Market by Application 1.3.1 Global Castration Resistant Prostate Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Ambulatory Surgical Centers 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Castration Resistant Prostate Cancer Treatment Market Perspective (2016-2027) 2.2 Castration Resistant Prostate Cancer Treatment Growth Trends by Regions 2.2.1 Castration Resistant Prostate Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Castration Resistant Prostate Cancer Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Castration Resistant Prostate Cancer Treatment Industry Dynamic 2.3.1 Castration Resistant Prostate Cancer Treatment Market Trends 2.3.2 Castration Resistant Prostate Cancer Treatment Market Drivers 2.3.3 Castration Resistant Prostate Cancer Treatment Market Challenges 2.3.4 Castration Resistant Prostate Cancer Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Castration Resistant Prostate Cancer Treatment Players by Revenue 3.1.1 Global Top Castration Resistant Prostate Cancer Treatment Players by Revenue (2016-2021) 3.1.2 Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Castration Resistant Prostate Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Castration Resistant Prostate Cancer Treatment Revenue 3.4 Global Castration Resistant Prostate Cancer Treatment Market Concentration Ratio 3.4.1 Global Castration Resistant Prostate Cancer Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Castration Resistant Prostate Cancer Treatment Revenue in 2020 3.5 Castration Resistant Prostate Cancer Treatment Key Players Head office and Area Served 3.6 Key Players Castration Resistant Prostate Cancer Treatment Product Solution and Service 3.7 Date of Enter into Castration Resistant Prostate Cancer Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Castration Resistant Prostate Cancer Treatment Breakdown Data by Type 4.1 Global Castration Resistant Prostate Cancer Treatment Historic Market Size by Type (2016-2021) 4.2 Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Type (2022-2027) 5 Castration Resistant Prostate Cancer Treatment Breakdown Data by Application 5.1 Global Castration Resistant Prostate Cancer Treatment Historic Market Size by Application (2016-2021) 5.2 Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Castration Resistant Prostate Cancer Treatment Market Size (2016-2027) 6.2 North America Castration Resistant Prostate Cancer Treatment Market Size by Type 6.2.1 North America Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021) 6.2.2 North America Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027) 6.2.3 North America Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2027) 6.3 North America Castration Resistant Prostate Cancer Treatment Market Size by Application 6.3.1 North America Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021) 6.3.2 North America Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027) 6.3.3 North America Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2027) 6.4 North America Castration Resistant Prostate Cancer Treatment Market Size by Country 6.4.1 North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2016-2021) 6.4.2 North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Castration Resistant Prostate Cancer Treatment Market Size (2016-2027) 7.2 Europe Castration Resistant Prostate Cancer Treatment Market Size by Type 7.2.1 Europe Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021) 7.2.2 Europe Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027) 7.2.3 Europe Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2027) 7.3 Europe Castration Resistant Prostate Cancer Treatment Market Size by Application 7.3.1 Europe Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021) 7.3.2 Europe Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027) 7.3.3 Europe Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2027) 7.4 Europe Castration Resistant Prostate Cancer Treatment Market Size by Country 7.4.1 Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2016-2021) 7.4.2 Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size (2016-2027) 8.2 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Type 8.2.1 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Application 8.3.1 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region 8.4.1 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Castration Resistant Prostate Cancer Treatment Market Size (2016-2027) 9.2 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type 9.2.1 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2027) 9.3 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application 9.3.1 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2027) 9.4 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country 9.4.1 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size (2016-2027) 10.2 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Type 10.2.1 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Application 10.3.1 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Country 10.4.1 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Active Biotech 11.1.1 Active Biotech Company Details 11.1.2 Active Biotech Business Overview 11.1.3 Active Biotech Castration Resistant Prostate Cancer Treatment Introduction 11.1.4 Active Biotech Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) 11.1.5 Active Biotech Recent Development 11.2 Diagnocure 11.2.1 Diagnocure Company Details 11.2.2 Diagnocure Business Overview 11.2.3 Diagnocure Castration Resistant Prostate Cancer Treatment Introduction 11.2.4 Diagnocure Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) 11.2.5 Diagnocure Recent Development 11.3 Glaxosmithkline 11.3.1 Glaxosmithkline Company Details 11.3.2 Glaxosmithkline Business Overview 11.3.3 Glaxosmithkline Castration Resistant Prostate Cancer Treatment Introduction 11.3.4 Glaxosmithkline Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) 11.3.5 Glaxosmithkline Recent Development 11.4 Northwest Biotherapeutics 11.4.1 Northwest Biotherapeutics Company Details 11.4.2 Northwest Biotherapeutics Business Overview 11.4.3 Northwest Biotherapeutics Castration Resistant Prostate Cancer Treatment Introduction 11.4.4 Northwest Biotherapeutics Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) 11.4.5 Northwest Biotherapeutics Recent Development 11.5 Millennium Pharmaceuticals 11.5.1 Millennium Pharmaceuticals Company Details 11.5.2 Millennium Pharmaceuticals Business Overview 11.5.3 Millennium Pharmaceuticals Castration Resistant Prostate Cancer Treatment Introduction 11.5.4 Millennium Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) 11.5.5 Millennium Pharmaceuticals Recent Development 11.6 Hologic 11.6.1 Hologic Company Details 11.6.2 Hologic Business Overview 11.6.3 Hologic Castration Resistant Prostate Cancer Treatment Introduction 11.6.4 Hologic Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) 11.6.5 Hologic Recent Development 11.7 Spectrum Pharmaceuticals 11.7.1 Spectrum Pharmaceuticals Company Details 11.7.2 Spectrum Pharmaceuticals Business Overview 11.7.3 Spectrum Pharmaceuticals Castration Resistant Prostate Cancer Treatment Introduction 11.7.4 Spectrum Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) 11.7.5 Spectrum Pharmaceuticals Recent Development 11.8 Abbott Laboratories 11.8.1 Abbott Laboratories Company Details 11.8.2 Abbott Laboratories Business Overview 11.8.3 Abbott Laboratories Castration Resistant Prostate Cancer Treatment Introduction 11.8.4 Abbott Laboratories Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) 11.8.5 Abbott Laboratories Recent Development 11.9 Bayer Healthcare Pharmaceuticals 11.9.1 Bayer Healthcare Pharmaceuticals Company Details 11.9.2 Bayer Healthcare Pharmaceuticals Business Overview 11.9.3 Bayer Healthcare Pharmaceuticals Castration Resistant Prostate Cancer Treatment Introduction 11.9.4 Bayer Healthcare Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) 11.9.5 Bayer Healthcare Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Hormonal Therapy Table 3. Key Players of Adding An Anti-Androgen Table 4. Key Players of Stopping An Anti-Androgen Table 5. Key Players of Estrogens Table 6. Key Players of Chemotherapy Table 7. Key Players of Radiation Therapy Table 8. Key Players of Others Table 9. Global Castration Resistant Prostate Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Castration Resistant Prostate Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Castration Resistant Prostate Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 12. Global Castration Resistant Prostate Cancer Treatment Market Share by Regions (2016-2021) Table 13. Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 14. Global Castration Resistant Prostate Cancer Treatment Market Share by Regions (2022-2027) Table 15. Castration Resistant Prostate Cancer Treatment Market Trends Table 16. Castration Resistant Prostate Cancer Treatment Market Drivers Table 17. Castration Resistant Prostate Cancer Treatment Market Challenges Table 18. Castration Resistant Prostate Cancer Treatment Market Restraints Table 19. Global Castration Resistant Prostate Cancer Treatment Revenue by Players (2016-2021) & (US$ Million) Table 20. Global Castration Resistant Prostate Cancer Treatment Market Share by Players (2016-2021) Table 21. Global Top Castration Resistant Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Castration Resistant Prostate Cancer Treatment as of 2020) Table 22. Ranking of Global Top Castration Resistant Prostate Cancer Treatment Companies by Revenue (US$ Million) in 2020 Table 23. Global 5 Largest Players Market Share by Castration Resistant Prostate Cancer Treatment Revenue (CR5 and HHI) & (2016-2021) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Castration Resistant Prostate Cancer Treatment Product Solution and Service Table 26. Date of Enter into Castration Resistant Prostate Cancer Treatment Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million) Table 29. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Type (2016-2021) Table 30. Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 31. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 32. Global Castration Resistant Prostate Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 33. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Application (2016-2021) Table 34. Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 35. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 36. North America Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million) Table 37. North America Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million) Table 38. North America Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million) Table 39. North America Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million) Table 40. North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million) Table 41. North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million) Table 42. Europe Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million) Table 43. Europe Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million) Table 44. Europe Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million) Table 45. Europe Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million) Table 46. Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million) Table 47. Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million) Table 48. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million) Table 49. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million) Table 50. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million) Table 51. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million) Table 52. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region (2016-2021) & (US$ Million) Table 53. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region (2022-2027) & (US$ Million) Table 54. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million) Table 55. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million) Table 56. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million) Table 57. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million) Table 58. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million) Table 59. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million) Table 60. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million) Table 61. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million) Table 62. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million) Table 63. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million) Table 64. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million) Table 65. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million) Table 66. Active Biotech Company Details Table 67. Active Biotech Business Overview Table 68. Active Biotech Castration Resistant Prostate Cancer Treatment Product Table 69. Active Biotech Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million) Table 70. Active Biotech Recent Development Table 71. Diagnocure Company Details Table 72. Diagnocure Business Overview Table 73. Diagnocure Castration Resistant Prostate Cancer Treatment Product Table 74. Diagnocure Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million) Table 75. Diagnocure Recent Development Table 76. Glaxosmithkline Company Details Table 77. Glaxosmithkline Business Overview Table 78. Glaxosmithkline Castration Resistant Prostate Cancer Treatment Product Table 79. Glaxosmithkline Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million) Table 80. Glaxosmithkline Recent Development Table 81. Northwest Biotherapeutics Company Details Table 82. Northwest Biotherapeutics Business Overview Table 83. Northwest Biotherapeutics Castration Resistant Prostate Cancer Treatment Product Table 84. Northwest Biotherapeutics Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million) Table 85. Northwest Biotherapeutics Recent Development Table 86. Millennium Pharmaceuticals Company Details Table 87. Millennium Pharmaceuticals Business Overview Table 88. Millennium Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product Table 89. Millennium Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million) Table 90. Millennium Pharmaceuticals Recent Development Table 91. Hologic Company Details Table 92. Hologic Business Overview Table 93. Hologic Castration Resistant Prostate Cancer Treatment Product Table 94. Hologic Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million) Table 95. Hologic Recent Development Table 96. Spectrum Pharmaceuticals Company Details Table 97. Spectrum Pharmaceuticals Business Overview Table 98. Spectrum Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product Table 99. Spectrum Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million) Table 100. Spectrum Pharmaceuticals Recent Development Table 101. Abbott Laboratories Company Details Table 102. Abbott Laboratories Business Overview Table 103. Abbott Laboratories Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million) Table 104. Abbott Laboratories Recent Development Table 105. Bayer Healthcare Pharmaceuticals Company Details Table 106. Bayer Healthcare Pharmaceuticals Business Overview Table 107. Bayer Healthcare Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product Table 108. Bayer Healthcare Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million) Table 109. Bayer Healthcare Pharmaceuticals Recent Development Table 110. Research Programs/Design for This Report Table 111. Key Data Information from Secondary Sources Table 112. Key Data Information from Primary Sources List of Figures Figure 1. Global Castration Resistant Prostate Cancer Treatment Market Share by Type: 2020 VS 2027 Figure 2. Hormonal Therapy Features Figure 3. Adding An Anti-Androgen Features Figure 4. Stopping An Anti-Androgen Features Figure 5. Estrogens Features Figure 6. Chemotherapy Features Figure 7. Radiation Therapy Features Figure 8. Others Features Figure 9. Global Castration Resistant Prostate Cancer Treatment Market Share by Application: 2020 VS 2027 Figure 10. Hospital Case Studies Figure 11. Ambulatory Surgical Centers Case Studies Figure 12. Castration Resistant Prostate Cancer Treatment Report Years Considered Figure 13. Global Castration Resistant Prostate Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 14. Global Castration Resistant Prostate Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Castration Resistant Prostate Cancer Treatment Market Share by Regions: 2020 VS 2027 Figure 16. Global Castration Resistant Prostate Cancer Treatment Market Share by Regions (2022-2027) Figure 17. Global Castration Resistant Prostate Cancer Treatment Market Share by Players in 2020 Figure 18. Global Top Castration Resistant Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Castration Resistant Prostate Cancer Treatment as of 2020 Figure 19. The Top 10 and 5 Players Market Share by Castration Resistant Prostate Cancer Treatment Revenue in 2020 Figure 20. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Type (2016-2021) Figure 21. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Type (2022-2027) Figure 22. North America Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. North America Castration Resistant Prostate Cancer Treatment Market Share by Type (2016-2027) Figure 24. North America Castration Resistant Prostate Cancer Treatment Market Share by Application (2016-2027) Figure 25. North America Castration Resistant Prostate Cancer Treatment Market Share by Country (2016-2027) Figure 26. United States Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Canada Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Castration Resistant Prostate Cancer Treatment Market Share by Type (2016-2027) Figure 30. Europe Castration Resistant Prostate Cancer Treatment Market Share by Application (2016-2027) Figure 31. Europe Castration Resistant Prostate Cancer Treatment Market Share by Country (2016-2027) Figure 32. Germany Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. France Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. U.K. Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Italy Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Russia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Nordic Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Share by Type (2016-2027) Figure 40. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Share by Application (2016-2027) Figure 41. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Share by Region (2016-2027) Figure 42. China Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Japan Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. South Korea Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Southeast Asia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. India Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Australia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Castration Resistant Prostate Cancer Treatment Market Share by Type (2016-2027) Figure 50. Latin America Castration Resistant Prostate Cancer Treatment Market Share by Application (2016-2027) Figure 51. Latin America Castration Resistant Prostate Cancer Treatment Market Share by Country (2016-2027) Figure 52. Mexico Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Brazil Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Share by Type (2016-2027) Figure 56. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Share by Application (2016-2027) Figure 57. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Share by Country (2016-2027) Figure 58. Turkey Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Saudi Arabia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. UAE Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Active Biotech Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021) Figure 62. Diagnocure Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021) Figure 63. Glaxosmithkline Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021) Figure 64. Northwest Biotherapeutics Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021) Figure 65. Millennium Pharmaceuticals Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021) Figure 66. Hologic Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021) Figure 67. Spectrum Pharmaceuticals Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021) Figure 68. Abbott Laboratories Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021) Figure 69. Bayer Healthcare Pharmaceuticals Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed

Active Biotech Diagnocure Glaxosmithkline Northwest Biotherapeutics Millennium Pharmaceuticals Hologic Spectrum Pharmaceuticals Abbott Laboratories Bayer Healthcare Pharmaceuticals